New pill aims to tame COPD Flare-Ups in Year-Long test
Disease control
Not yet recruiting
This study is testing whether a new tablet called RSS0343 can help people with COPD by reducing the number of serious symptom flare-ups they experience. About 237 adults with a history of COPD flare-ups will take the pill or a placebo for 48 weeks to see if it's safe and effectiv…
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC